If you have PCOS and you're pregnant, or trying to become pregnant, chances are nobody sat you down and explained what insulin resistance actually does to your body during this stage. You were probably told to "watch your diet" or handed a glucose tolerance test appointment without much context.

You're not imagining it. The connection between PCOS, insulin, and pregnancy is one of the most important, and most under-discussed, topics in women's hormonal health.

This article is going to change that.

We're going to break down what the research actually says about myo-inositol, why insulin resistance is such a central issue for women with PCOS during pregnancy, and what practical steps you can take to support your metabolic health right now.

Insulin resistance is when your body's cells stop responding properly to insulin — the hormone your pancreas produces to help move glucose out of your bloodstream and into your cells for energy.

When cells become resistant, your pancreas compensates by pumping out more insulin. Chronically elevated insulin then triggers a cascade of hormonal disruptions: it stimulates the ovaries to produce more androgens (male hormones like testosterone), disrupts ovulation, and interferes with your body's ability to regulate blood sugar efficiently.

This is the research on this topic, and it's actually pretty clear: between 50–70% of women with PCOS have some degree of insulin resistance, regardless of body weight [Diamanti-Kandarakis & Dunaif, 2012]. This isn't a lifestyle failure. It's a physiological pattern embedded in the condition itself.

During pregnancy, the stakes shift.

Your body naturally becomes more insulin resistant as pregnancy progresses — this is a normal adaptation that helps redirect glucose to the developing baby. But for women with PCOS who are already working from a baseline of compromised insulin sensitivity, this normal shift can tip into gestational diabetes, excessive weight gain, elevated blood pressure, and complications that affect both mother and child.

Understanding this isn't meant to frighten you. It's meant to give you the context no one else has given you — so you can act on it intelligently.

Myo-inositol is a naturally occurring compound classified within the B-vitamin family. It's present in every cell of the human body and plays a particularly important role in how your cells respond to insulin.

Think of insulin as a key and your cell receptor as a lock. Myo-inositol is part of the signalling mechanism that makes the lock work. Without adequate inositol, the key doesn't turn properly — and insulin resistance develops or worsens.

Here's where it gets relevant for PCOS specifically: women with PCOS often have lower circulating levels of myo-inositol compared to women without the condition [Nestler et al., 1999]. This isn't coincidental. It's part of why insulin dysregulation is so common in this population.

The research on myo-inositol supplementation has grown substantially over the last two decades. Studies consistently show it can improve insulin sensitivity, support ovulation, and reduce androgen levels in women with PCOS — effects that matter enormously during both preconception and pregnancy.

Myo-inositol improves insulin sensitivity by restoring intracellular signalling pathways that become impaired in PCOS, helping cells respond more effectively to insulin.

A landmark study by Facchinetti et al. (2012), published following an international consensus conference on inositol in obstetrics and gynaecology, confirmed that myo-inositol plays a meaningful role in managing metabolic parameters in women with PCOS — including those who are pregnant. The consensus highlighted improvements in insulin sensitivity as one of the most clinically significant benefits [Facchinetti et al., 2012].

What does this look like in practice? When insulin sensitivity improves:

• Blood glucose levels stabilise more easily after meals
• Insulin spikes become less frequent and less severe
• Androgen production from the ovaries reduces
• Inflammatory markers often decrease alongside metabolic improvement
• Energy levels tend to become more consistent

These aren't just numbers on a blood test. They translate to a more stable pregnancy experience — fewer crashes, less relentless hunger, and a lower physiological stress load on your body.

Yes — research suggests myo-inositol supplementation can significantly lower the risk of gestational diabetes in pregnant women with PCOS.

Gestational diabetes mellitus (GDM) affects approximately 2–10% of all pregnancies — but that risk is considerably higher for women with PCOS. The combination of pre-existing insulin resistance and the normal insulin resistance of pregnancy creates the perfect conditions for blood sugar dysregulation to escalate into a diagnosable condition.

In a well-designed randomised controlled trial by D'Anna et al. (2013), pregnant women with a family history of type 2 diabetes who received myo-inositol supplementation showed a markedly lower incidence of gestational diabetes compared to those who received a placebo. The myo-inositol group also demonstrated improvements in fasting glucose levels and reduced insulin resistance scores [D'Anna et al., 2013].

Why does this matter beyond the diagnosis itself? Gestational diabetes is associated with:

• Higher birth weight (macrosomia) and associated delivery complications
• Increased likelihood of C-section
• Elevated long-term risk of type 2 diabetes for both mother and child
• Neonatal hypoglycaemia (low blood sugar in the newborn after birth)

Preventing gestational diabetes isn't just about convenience. It's about trajectory — for you and your baby.

The benefits of myo-inositol during pregnancy with PCOS extend beyond blood glucose alone.

Studies have documented improvements in several metabolic markers that are commonly disrupted in women with PCOS:

Lipid profiles: Myo-inositol has been associated with reductions in triglyceride levels and improvements in overall lipid balance. Elevated triglycerides are a common feature of insulin-resistant PCOS and carry cardiovascular implications [Facchinetti et al., 2012].

Androgen levels: By improving insulin signalling, myo-inositol can indirectly reduce ovarian androgen production. Elevated testosterone is both a symptom and a driver of PCOS — reducing it supports more regular ovulation and can improve symptoms like acne, excess hair growth, and cycle irregularity.

Hormonal regulation: Some studies have shown modest improvements in LH (luteinising hormone) to FSH (follicle stimulating hormone) ratios in PCOS patients using inositol supplementation — a ratio that is frequently dysregulated in the condition and linked to ovulatory dysfunction.

Blood pressure: There is emerging evidence that myo-inositol may contribute to modest improvements in blood pressure parameters, which is relevant given the elevated risk of hypertensive conditions in PCOS pregnancies.

This is what root-cause thinking looks like in practice. Rather than managing one symptom at a time, myo-inositol addresses the underlying metabolic dysfunction — and the downstream benefits follow.

If you're reading this before you're pregnant — because you're trying to conceive, or because you're thinking ahead — this section is for you.

One of the most significant things you can do for a healthy PCOS pregnancy is to begin supporting your insulin sensitivity before conception.

Here's why. The metabolic environment you're in during the early weeks of pregnancy — often before you even know you're pregnant — influences implantation success, early foetal development, and your baseline insulin response throughout the pregnancy. Starting inositol support only after a positive test means you've already navigated the most hormonally volatile early weeks without it.

This is what I wish someone had told me when I was trying to conceive. The preconception window is one of the most powerful opportunities for metabolic and hormonal preparation — and it's one of the most under-utilised.

Supporting your body before pregnancy isn't about perfection. It's about giving your system the inputs it needs to function well during one of its most demanding periods.

Our award-winning MyOva Preconception supplement was formulated specifically with this in mind. It contains myo-inositol alongside a comprehensive suite of nutrients that support hormonal balance, metabolic function, and pregnancy preparation in women with PCOS — including:

• N-Acetyl Cysteine (NAC): A powerful antioxidant that supports ovarian function and egg quality, with growing evidence for its role in improving insulin sensitivity in PCOS
• Alpha-Lipoic Acid: A metabolic cofactor that enhances glucose uptake and has shown promise in improving insulin resistance markers
• Magnesium Citrate: Frequently depleted in insulin-resistant states; essential for over 300 enzymatic reactions including glucose metabolism
• Zinc Bisglycinate: Important for ovulation, hormone receptor function, and reducing androgen activity
• Chromium Picolinate: A trace mineral involved in insulin receptor sensitivity and blood sugar regulation
• 5-Methyltetrahydrofolate (active folate): The bioavailable form of folate — crucial for early neural tube development and especially important for women with MTHFR variants who cannot efficiently convert standard folic acid
• Ubiquinol (CoQ10): Supports mitochondrial energy production in eggs and has been studied for its role in improving egg quality
• Methylcobalamin (B12), Vitamin D3, and a full B-complex: Foundational micronutrients for hormonal health, mood regulation, and pregnancy readiness

It's not a magic fix. But it gives your body what it's often missing — a comprehensive, evidence-informed foundation for the work your body is doing.

The most studied dose of myo-inositol for PCOS is 2–4g per day, often combined with folic acid , taken consistently over several months.

A few practical points worth knowing:

Consistency matters more than timing. The benefits of myo-inositol are cumulative. Studies showing meaningful improvements in insulin sensitivity and gestational diabetes risk typically ran for 12–24 weeks. This is not a supplement you take for a fortnight and assess. Give it a full cycle — ideally three months — before evaluating its impact.

Combination formulas have advantages. Many clinical trials have used myo-inositol alongside D-chiro-inositol at a 40:1 ratio, which reflects the natural physiological ratio in healthy tissue. Others have combined it with alpha-lipoic acid or other metabolic cofactors to enhance its insulin-sensitising effects. A well-formulated product handles this for you.

Lifestyle factors amplify the effect. Myo-inositol works best when paired with blood sugar-stabilising eating habits — eating protein with every meal, avoiding refined carbohydrate spikes, managing stress, and incorporating movement that your body can sustain. These aren't restrictions. They're the context in which supplementation becomes most effective.

Always consult your healthcare provider before starting or changing supplementation during pregnancy. While the research on myo-inositol is reassuring, every individual's medical history is different — especially for those managing existing medications, blood sugar conditions, or complex PCOS presentations.

If your blood tests came back "normal" and your doctor sent you on your way — this is for you.

Standard NHS testing often doesn't include fasting insulin or HOMA-IR (a calculated measure of insulin resistance). It checks fasting glucose, which can appear within normal range even when insulin resistance is already well established. By the time fasting glucose is elevated, insulin resistance has typically been present for years.

This means many women with PCOS are being told their metabolic health is fine when it isn't. Not because their doctors are negligent — but because the system uses blunt tools where precision is needed.

Your body is trying to tell you something. The sugar cravings, the 3pm energy crashes, the weight that shifts easily to your abdomen, the cycles that won't regulate — these are metabolic signals, not character flaws.

Hormonal literacy isn't complicated — it's just rarely taught.

If you want to understand your insulin picture better, ask your GP or a private practitioner to test:

• Fasting insulin (alongside fasting glucose)
• HOMA-IR (calculated from fasting insulin and glucose)
• HbA1c (a three-month average of blood glucose)
• Triglycerides (elevated in insulin-resistant states)

And advocate for yourself in those appointments. You deserve a full picture, not a partial one.

The research on myo-inositol for PCOS and pregnancy continues to grow. The studies referenced in this article — Facchinetti et al. (2012) and D'Anna et al. (2013) — represent established, peer-reviewed work in this field. Additional research has continued to build on these foundations over the past decade.

Evidence-based doesn't mean "proven to work for everyone." It means we have well-designed research showing consistent patterns — which is a meaningful basis for clinical and personal decision-making.

It also means being honest about what we don't yet know. Individual responses vary. The mechanisms are not fully elucidated. Long-term data on supplementation in pregnancy continues to be gathered.

This is why working with a knowledgeable healthcare provider matters — not to defer every decision to them, but to make informed decisions together, with you in the driving seat.

Your diagnosis is a starting point, not a verdict. And understanding your metabolic health is one of the most empowering things you can do — for your pregnancy, and for your long-term health.

Myo-inositol is a naturally occurring compound found in food and produced by the body. It has been used in multiple clinical trials involving pregnant women, including those with PCOS, with no significant adverse effects reported. However, always discuss supplementation with your midwife or obstetrician before starting or continuing during pregnancy, particularly if you are managing any additional conditions or medications.

Most clinical studies show meaningful improvements in insulin sensitivity and related metabolic markers over 12–24 weeks of consistent supplementation. Some women notice changes in energy levels and sugar cravings sooner — within four to eight weeks — but the deeper metabolic shifts take longer. Consistency over months matters more than short-term outcomes.

Research, including the D'Anna et al. (2013) randomised controlled trial, suggests that myo-inositol supplementation can significantly reduce the incidence of gestational diabetes in high-risk women. It is not a guarantee, and it does not replace dietary management, regular monitoring, or medical guidance. But the evidence for its protective role is genuinely encouraging.

Yes — by improving insulin sensitivity, myo-inositol can indirectly reduce androgen levels, support more regular ovulation, improve cycle regularity, and help manage symptoms like acne, excess hair growth, and weight distribution. The metabolic and hormonal systems in PCOS are deeply interconnected, so supporting one often improves others.

Ideally, begin supporting your insulin sensitivity and hormonal health during the preconception period — at least three months before you start trying to conceive. This allows time for metabolic shifts to establish, and means you're already in a supported state during the critical early weeks of pregnancy. A comprehensive preconception supplement that includes myo-inositol alongside pregnancy-supportive nutrients offers the most complete foundation.

1. Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews, 33(6), 981–1030.

2. Nestler, J.E., Jakubowicz, D.J., Reamer, P., Gunn, R.D., & Allan, G. (1999). Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine, 340(17), 1314–1320.

3. Facchinetti, F., Bizzarri, M., Benvenga, S., D'Anna, R., Lanzone, A., Soulage, C., … Valentino, V. (2012). Results from the international consensus conference on Myo-Inositol and D-chiro-inositol in obstetrics and gynecology: The link between metabolic syndrome and PCOS. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 166(1), 1–6.

4. D'Anna, R., Di Benedetto, V., Rizzo, P., Raffone, E., & Interdonato, M. (2013). Myo-Inositol supplementation and gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: A prospective, randomized, placebo-controlled study. Diabetes Care, 36(4), 854–857.

5. Unfer, V., Carlomagno, G., Dante, G., & Facchinetti, F. (2012). Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology, 28(7), 509–515.